Broadening Eligibility Criteria and Diversity among Patients for Cancer Clinical Trials-Reference-Cited by-同舟云学术

Broadening Eligibility Criteria and Diversity among Patients for Cancer Clinical Trials

Published:2024-03-26 Issue:4 Volume:3 Page:
ISSN:2766-5526
Container-title:NEJM Evidence
language:en
Short-container-title:NEJM Evidence

Author:

Kaur Maneet¹,Frahm Filip¹,Lu Yichen¹,Ascha Mustafa S.¹,Guadamuz Jenny S.¹²,Dotan Efrat³,Gottesman Adam S.¹,Leybovich Barry C.¹,Sondhi Arjun¹,Zhao Yihua¹,Meropol Neal J.¹⁴,Royce Trevor J.¹⁵

Affiliation:

1. Flatiron Health, New York

2. School of Public Health, Division of Health Policy and Management, University of California, Berkeley, Berkeley

3. Department of Medical Oncology, Fox Chase Cancer Center, Philadelphia

4. Case Comprehensive Cancer Center, Case Western Reserve University, Cleveland

5. Department of Radiation Oncology, Wake Forest University School of Medicine, Winston-Salem, NC

Publisher

Massachusetts Medical Society

Reference30 articles.

1. Bibbins-Domingo K, Helman A, eds. Improving representation in clinical trials and research: building research equity for women and underrepresented groups. Washington, DC: National Academies Press, 2022.

2. U.S. Food and Drug Administration. Diversity plans to improve enrollment of participants from underrepresented racial and ethnic populations in clinical trials; draft guidance for industry. April 2022 (https://www.fda.gov/regulatory-information/search-fda-guidance-documents/diversity-plans-improve-enrollment-participants-underrepresented-racial-and-ethnic-populations).

3. U.S. Government. H.R.2617 - Consolidated Appropriations Act 2023

4. 117th Congress (2021-2022). December 29 2022 (https://www.congress.gov/bill/117th-congress/house-bill/2617).

5. Improving Diversity in Clinical Trials by Using Real-world Data to Define Eligibility Criteria

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Re-Envisioning Electronic Health Records to Optimize Patient-Centered Cancer Care, Quality, Surveillance, and Research;JCO Oncology Practice;2024-08-05

2. Reflecting the Real World of Cancer Care — The Impact of Broadening Trial Eligibility;NEJM Evidence;2024-03-26